Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma

Cancer

Volumn 91, Issue 8, 2001, Pages 1487-1493

  Izumi, Miiru ^a   Nakanishi, Yoichi ^a   Takayama, Koichi ^a   Kimotsuki, Kanehito ^a   Inoue, Koji ^a   Wataya, Hiroshi ^a   Minami, Takahiro ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bone metastases; Bone resorption; Deoxypyridinoline; Lung carcinoma; Pyridinoline cross linked C telopeptides of Type I collagen; Pyridinoline cross linked N telopeptides of Type I collagen

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN DERIVATIVE; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BONE TURNOVER; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METABOLITE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0035871392     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8<1487::AID-CNCR1156>3.0.CO;2-2     Document Type: Article

References (19)

1. The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changes
2. A specific immunoassay for monitoring human bone resorption: Quantitation of Type I collagen cross-linked N-telopeptides in urine
3. Urinary bone resorption markers in patients with metabolic bone disorders
4. Serum markers of Type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry
5. Use of bone turn over marker, pyridinoline cross-linked carboxyterminal telopeptide of Type I collagen (1CTP), in the assessment and monitoring of bone metastasis in prostate cancer
6. Biochemical markers of bone turn over in patients with metastatic bone disease
7. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis
8. The meaning and use of the area under a receiver operating characteristic (ROC) curve
9. Serum and urinary markers of bone remodeling: Assessment of bone turn over
10. Cross-linking in collagen and elastin
11. Collagen cross-linking aminoacids
12. Radioimmunoassay for pyridinoline cross-linked carboxy-terminal telopeptide of Type I collagen: A new serum marker of bone collagen degradation
13. Serum concentrations of Type I collagen carboxyterminal telopeptide (1CTP) and Type I procollagen carboxy- and aminoterminal propeptides (PICP. PINP) as markers of metastatic bone disease in breast cancer
14. New biomarkers of bone resorption
15. Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis
16. Diagnostic validity of bone metabolic markers for bone metastasis
17. Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer
18. Type I collagen metabolites as tumor markers in patients with lung carcinoma